The effect and mechanism of Silymarin on liver fibrosis in mice

Li-bo CAO,Bing LI,Zuo-jun LI,Juan-juan HUANG,Lin-qi OUYANG,Han HUANG,Shi-kun LIU
DOI: https://doi.org/10.3321/j.issn:1001-1978.2009.06.024
2009-01-01
Abstract:Aim: To observe the anti-fibrosis effect and mechanism of Silymarin (SIL) on mice hepatic fibrosis caused by alcohol and CCl4. Methods: 50 Kunming mice were randomly divided into 5 groups. Fibrosis model group was given CCl4 through subcutaneous injections plus alcohol oral administration. The treated groups were divided into low dose (50 mg·kg-1 body weight), medium dose (100 mg·kg -1 body weight), high dose(200 mg·kg-1 body weight) of SIL and normal group was given plant oil through subcutaneous injections and physiological saline oral administration. All groups were raised for 8 weeks. ALT and AST of serum, the histopathology of the mice liver and the mRNA expression of TGF-β1,α-SMA and collagen-I were detected. Results: The hepatic fibrosis mice models were successfully made, the level of serum AST, ALT and TGF-β1,α-SMA and collagen- I mRNA of liver were increased in model groups, SIL decreased the level of serum ALT, AST and the expression of TGF-β1, α-SMA and collagen- I mRNA, the medium dose of SIL had the most significant effect. Conclusion: SIL significantly reduces alcohol and CCl4-induced mice hepatic fibrosis, probably by reducing the expression of TGF-β1 mRNA and then inhibiting the proliferation of HSC.
What problem does this paper attempt to address?